Our results indicate that beyond targeting the deacetylase activity of SIRT2, developing novel methods to enhance the association of SIRT2 with OGG1 might be a promising approach for cancer prevention and the treatment of neurodegenerative diseases that are associated with the rise in genomic instability resulting from oxidative stress (76). The gene discussed is OGG1; the disease is neurodegenerative disease.